Company Search:
Advanced Search
Sponsored Links
Lavipharm SA Company Snapshot
Lavipharm SA operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lavipharm SA with three other pharmaceutical manufacturers in Europe: New Nordic Healthbrands AB of SWEDEN (2019 sales of 452.61 million Swedish Kronor [US$51.15 million] ), Science In Sport Plc of UNITED KINGDOM (£50.57 million [US$64.84 million] of which 51% was PhD), and Venture Life Group plc which is also based in UNITED KINGDOM (£20.21 million [US$25.91 million] of which 67% was Customer Brands).

Sales Analysis. Lavipharm SA reported sales of 33.59 million Euro (US$39.52 million) for the year ending December of 2019. This represents a decrease of 1.4% versus 2018, when the company's sales were 34.06 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Lavipharm SA
  Stock Performance Chart for Lavipharm SA
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): .26
(Figures in Euros )
1 Week -0.8%   13 Weeks -15.5%  
4 Weeks -12.7%   52 Weeks -4.4%  
Lavipharm SA Key Data:
  Ticker: LAVI Country: Greece
  Exchanges: ATH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 33,588,000
(Year Ending Jan 2020).
Employees: 314
  Currency: Euros Market Cap: 13,383,230
  Fiscal Yr Ends: December Shares Outstanding: 51,081,030
  Share Type: Kini Metohi Closely Held Shares: 26,827,757
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.